ELIZABETH HILL to Female
This is a "connection" page, showing publications ELIZABETH HILL has written about Female.
Connection Strength
0.117
-
Extended Versus Standard Hypomethylating Agent Dosing in Combination With Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia. Hematol Oncol. 2026 May; 44(3):e70198.
Score: 0.009
-
Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 years. Blood Adv. 2026 Jan 13; 10(1):168-180.
Score: 0.009
-
A Bayesian beta-binomial piecewise growth mixture model for longitudinal overdispersed binomial data. Stat Methods Med Res. 2024 10; 33(10):1859-1876.
Score: 0.008
-
Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma. Clin Cancer Res. 2024 Oct 01; 30(19):4482-4490.
Score: 0.008
-
Genome wide association study of clinical duration and age at onset of sporadic CJD. PLoS One. 2024; 19(7):e0304528.
Score: 0.008
-
National Breast, Cervical, and Colorectal Cancer Screening Use in Federally Qualified Health Centers. JAMA Intern Med. 2024 Jun 01; 184(6):671-679.
Score: 0.008
-
Camp health services in the state of Michigan. Wilderness Environ Med. 2004; 15(4):274-83.
Score: 0.008
-
County-Level Trends in Cervical Cancer Incidence, Stage at Diagnosis, and Mortality in Kentucky. JAMA Netw Open. 2023 10 02; 6(10):e2338333.
Score: 0.008
-
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled Trial. JAMA Oncol. 2021 Nov 01; 7(11):1678-1685.
Score: 0.007
-
The composition of human vaginal microbiota transferred at birth affects offspring health in a mouse model. Nat Commun. 2021 11 01; 12(1):6289.
Score: 0.007
-
Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma. Oncologist. 2021 04; 26(4):288-e541.
Score: 0.006
-
A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma. Cancer. 2021 03 15; 127(6):894-904.
Score: 0.006
-
Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients. Blood Cancer J. 2019 02 04; 9(2):15.
Score: 0.006
-
Remission and Progression-Free Survival in Patients With Newly Diagnosed Multiple Myeloma Treated With Carfilzomib, Lenalidomide, and Dexamethasone: Five-Year Follow-up of a Phase 2 Clinical Trial. JAMA Oncol. 2018 12 01; 4(12):1781-1783.
Score: 0.006
-
(18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma. Br J Haematol. 2016 08; 174(3):410-6.
Score: 0.005
-
Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2015 Aug 20; 33(24):2695-704.
Score: 0.004
-
Investigation of Epidemiological Factors as Barriers to Indicated Radiation Therapy in Post-Mastectomy Breast Cancer Patients in South Carolina. J S C Med Assoc. 2015 Mar-Apr; 111(1):16-20.
Score: 0.004